Rising Cancer Incidences Drive Growth In The Gene Therapy Market: An Emerging Driver Transforming The Gene Therapy Market Landscape

The Gene Therapy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Gene Therapy Market?
In recent times, the size of the gene therapy market has seen a significant expansion. It is expected to increase from $12.52 billion in 2024 to $16.36 billion in 2025, marking a compound annual growth rate (CAGR) of 30.7%. Factors such as heightened pharmaceutical research and development spending, an uptick in public-private collaborations, government funding, and an increased number of spinal muscular atrophy cases have all contributed to the growth experienced within this historic period.

The gene therapy industry is projected to witness substantial expansion in the ensuing years, with its market size expected to reach $31.48 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 17.8%. The surge for the forecast period can be credited to a rise in cancer incidents, an expanding elder population, a hike in spending on research and development in the pharmaceutical field, and an increasing emphasis on gene therapy which will push market growth. Key trends during the forecast period will involve bolstering business procedures by securing regulatory approvals, enhancing business engagements through strategic collaborations and alliances, inflating business competencies via calculated acquisitions, and buttressing operational aptitudes via business expansion.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395

What Are the Different Gene Therapy Market Segments?
The gene therapy market covered in this report is segmented -

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy
2) By Vector: Viral Vector, Non-Viral Vector
3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders
4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:
1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations
2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

What Are the Primary Drivers Shaping the Gene Therapy Market?
The escalating instances of cancer and other targeted diseases are necessitating efficient treatments, thereby bolstering the expansion of the gene therapy market. The global surge in cancer cases is expected to fuel the rise of the gene therapy market in the future. For example, as per the American Cancer Society's January 2022 data, the US is projected to witness 1.9 million new cases of cancer and 609,360 deaths due to cancer, amounting to approximately 1,670 fatalities daily. Lung, prostate, bowel, and female breast cancer are the four most prevalent types of cancer across the globe, making up 43% of all new cancer diagnoses. Consequently, the global spike in cancer incidence rates is projected to stimulate demand for the gene therapy market in the upcoming years. Gene therapy is amongst the most efficacious treatments in the field of oncology. This approach involves introducing new genes to a cancer cell or its adjacent tissue to initiate cell death or retard cancer growth.

Which Companies Are Leading in the Gene Therapy Market?
Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi

What Are the Major Trends Shaping the Gene Therapy Market?
The gene therapy market is increasingly adopting machine learning and artificial intelligence technologies. Artificial intelligence (AI) replicates human intelligence in machines, teaching them to demonstrate behaviour that reflects natural intelligence. As a component of AI, machine learning aids businesses in the gene therapy sector to carry out comprehensive data analyses, gain insights on tumor-immune cell interactions, and enable more precise assessment of tissue samples, a subject often contended among multiple evaluators. To illustrate, Form Bio, a software company from the USA focused on life sciences, introduced FORMsightAI in May 2023, an AI-driven solution suite designed for projecting and enhancing production outputs for cell and gene therapy structures. Combining state-of-the-art, adaptable AI algorithms with Form Bio's foundational platform, and a proficient team with experience in biology, bioinformatics, and data science, FORMsightAI is a comprehensive solution. It tackles common challenges of construct truncations and manufacturing contaminations faced by cell and gene therapy developers, these issues being significant contributors to inadequately low production returns, lengthy timeframes to market, and issues related to therapeutic safety.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

What Are the Top Revenue-Generating Geographies in the Gene Therapy Market?
North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Gene Therapy Market?
2. What is the CAGR expected in the Gene Therapy Market?
3. What Are the Key Innovations Transforming the Gene Therapy Industry?
4. Which Region Is Leading the Gene Therapy Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.